Amgen names senior VP, global regulatory affairs
This article was originally published in Scrip
Executive Summary
Amgen has named Dr Steven K Galson senior vice-president, global regulatory affairs and safety – effective 19 May 2014. Dr Galson joined the Thousand Oaks, California-based company in October 2010 as vice-president of global regulatory affairs. Prior to joining Amgen he was senior vice-president for civilian health operations and chief health scientist at Science Applications International Corporation.